Security Snapshot

Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS) Institutional Ownership

CUSIP: H5870P102

13F Institutional Holders and Ownership History from Q1 2023 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

40

Shares (Excl. Options)

18,020,789

Price

$19.97

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Ordinary Shares, CHF 0.01 par value per share
Symbol
OCS on Nasdaq
Shares outstanding
58,862,367
Price per share
$26.59
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
18,020,789
Total reported value
$361,237,998
% of total 13F portfolios
0%
Share change
+4,525,547
Value change
+$90,374,744
Number of holders
40
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • OCS - Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share is tracked under CUSIP H5870P102.
  • 40 institutions reported positions in Q4 2025.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 40 to 3 between Q4 2025 and Q1 2026.
  • Reported value moved from $361,237,998 to $73,046,449.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 40 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP H5870P102?
CUSIP H5870P102 identifies OCS - Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LSP 7 Cooperative UA 14% $101,078,348 5,752,894 LSP 7 Cooperatieve U.A. 31 Dec 2024
Pivotal bioVenture Partners Fund I, L.P. 4.9% $49,946,544 2,815,476 Nan Fung Group Holdings Limited 30 Sep 2025
BVCF IV, L.P. 4.1% -18% $73,082,691 +$7,350,309 2,436,902 +11% BVCF IV, L.P. 13 Feb 2026

As of 31 Dec 2025, 40 institutional investors reported holding 18,020,789 shares of Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS). This represents 31% of the company’s total 58,862,367 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS) together control 30% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
EQT Fund Management S.a r.l. 10% 5,900,294 0% 11% $117,828,871
Gildi - lifeyrissjodur 4.2% 2,447,985 0% 23% $50,250,171
Pivotal bioVenture Partners Investment Advisor LLC 3.9% 2,288,658 -0.53% 18% $45,704,500
Aberdeen Group plc 3% 1,746,946 +39% 0.05% $34,886,512
WELLINGTON MANAGEMENT GROUP LLP 2.3% 1,356,179 0% $27,082,895
SR One Capital Management, LP 1.1% 641,022 +99% 1.8% $12,801,209
Saturn V Capital Management LP 0.88% 516,761 1.9% $10,319,717
Nan Fung Group Holdings Ltd 0.87% 514,702 0% 9.2% $10,278,599
PERCEPTIVE ADVISORS LLC 0.84% 493,827 0.18% $9,861,725
Alyeska Investment Group, L.P. 0.56% 331,332 +152% 0.02% $6,616,700
Woodline Partners LP 0.34% 201,200 +140% 0.02% $4,017,964
SYQUANT CAPITAL SAS 0.33% 192,722 0.47% $3,849,000
FOLKETRYGDFONDET 0.31% 182,800 0.08% $3,650,516
Propel Bio Management, LLC 0.29% 172,839 2.9% $3,451,595
CITADEL ADVISORS LLC 0.28% 165,487 0% $3,304,775
NEXTBio Capital Management LP 0.25% 149,750 0% 1.8% $2,990,508
Compagnie Lombard Odier SCmA 0.18% 107,300 +11% 0.02% $2,142,781
ACUTA CAPITAL PARTNERS, LLC 0.17% 101,777 0% 1.4% $2,032,487
Simplify Asset Management Inc. 0.17% 98,765 0.03% $1,972,337
BANK OF AMERICA CORP /DE/ 0.11% 63,951 +66% 0% $1,277,101
ALPS ADVISORS INC 0.08% 46,947 0.01% $937,532
UBS Group AG 0.08% 45,916 -39% 0% $916,943
MARSHALL WACE, LLP 0.08% 45,773 0% $914,086
HRT FINANCIAL LP 0.07% 43,914 0% $876,000
GEODE CAPITAL MANAGEMENT, LLC 0.06% 36,061 +23% 0% $720,138

Institutional Holders of Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 2,758,723 $73,046,449 +$287,162 $26.59 3
2025 Q4 18,020,789 $361,237,998 +$90,374,744 $19.97 40
2025 Q3 10,893,907 $191,723,678 -$2,123,823 $17.58 20
2025 Q2 5,105,646 $99,100,716 +$2,469,586 $19.41 23
2025 Q1 4,978,440 $94,739,711 +$28,331,355 $19.03 20
2024 Q4 3,493,543 $59,378,651 +$8,163,517 $17.00 12
2024 Q3 3,013,203 $36,946,526 -$3,838,556 $12.26 10
2024 Q2 3,327,448 $39,763,128 -$771,604 $11.95 10
2024 Q1 3,392,028 $40,873,938 -$7,013,425 $12.05 9
2023 Q4 3,983,142 $44,273,231 +$11,534,877 $11.12 7
2023 Q3 2,916,785 $32,106,736 -$2,324,387 $11.00 9
2023 Q2 3,125,204 $38,536,753 +$147,595 $12.33 9
2023 Q1 3,123,421 $23,191,122 +$23,191,122 $7.43 7